SLE – Hematopoietic stem cell transplantation for systemic lupus erythematosus

AUTOR(ES)

Burt, Richard K

FONTE

BioMed Central

RESUMO

Hematopoietic stem cell transplantation was first reported for patients with systemic lupus erythematosus in 1997. The procedure has since been performed worldwide including in Europe, in Brazil, and in China. A National Institutes of Health-funded phase III clinical trial of hematopoietic stem cell transplantation for refractory systemic lupus erythematosus is anticipated to begin in 2003. Encouraging responses are raising new hope about the role of adult hematopoietic stem cells in systemic lupus erythematosus.

Documentos Relacionados

• Systemic lupus erythematosus (SLE) and thymoma
• SLE - Systemic lupus erythematosus: a BLySful, yet BAFFling, disorder
• Is immunogenetic susceptibility to neuropsychiatric systemic lupus erythematosus (SLE) different from non-neuropsychiatric SLE?
• Risk factors for cytomegalovirus disease in systemic lupus erythematosus (SLE): a systematic review
• The need for endodontic treatment and systemic characteristics of hematopoietic stem cell transplantation patients